艾森塔
AZTA
34.09
-2.43
-6.65%
艾森塔
US · AZTA
#2893 按市值排名
上市于 1970
34.09
-2.43
-6.65%
实时 - 追踪5344个代码 - 心跳于13秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
增持
- 机构持股总比例上升了0.5个百分点。
机构持股
- 机构持股比例
- 115.88% +0.49pp
- 机构数量
- 298
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向分歧机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund84.34%
Hedge Fund21.66%
Public Company5.26%
Government Pension Fund1.90%
Private Company1.08%
Insurance Company0.98%
Individual/Insider0.67%
Sovereign Wealth Fund0.49%
Family Office/Trust0.13%
主要股东 截至 2026-06-30
BlackRock
17.19% · 7.53M 股
Politan Capital Management, L.P.
10.55% · 4.62M 股
Vanguard Portfolio Management, LLC
5.69% · 2.49M 股
Vanguard Capital Management, LLC
4.89% · 2.14M 股
State Street Global Advisors
4.25% · 1.86M 股
MFS Investment Management
3.25% · 1.42M 股
D. E. Shaw & Co., L.P.
3.06% · 1.34M 股
Front Street Capital Management, Inc.
2.97% · 1.30M 股
Dimensional Fund Advisors
2.81% · 1.23M 股
Allspring Global Investments, LLC
2.72% · 1.19M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 38次买入 · 12次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Politan Capital Management, L.P. | -- | 10.55% |
| Martin Madaus | Independent Director | 0.10% |
| Robyn Davis | Independent Director | 0.09% |
| John P. Marotta | President | 0.09% |
| Lawrence Lin | Chief Financial Officer | 0.06% |
| Erica McLaughlin | Independent Director | 0.05% |
| Frank Casal | Independent Director | 0.05% |
| William Cornog | Independent Director | 0.04% |
| Alan Malus | Independent Director | 0.04% |
| Tina Nova | Independent Director | 0.04% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-21 | Martin Madaus | Independent Director | Sale to Issuer | -1,456 | $34.28 |
| 2026-09-14 | Erik Bello | Vice President, Chief Accounting Officer & Principal Accounting Officer | Other Acquisition | +4,586 | -- |
| 2026-09-13 | Martin Madaus | Independent Director | Other Acquisition | +36,653 | -- |
| 2026-09-13 | Ephraim Starr | Senior Vice President | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Olga Pirogova | Senior VP & Chief HR Officer | Other Acquisition | +15,272 | -- |
| 2026-09-13 | William Martin | President of Multiomics Business | Other Acquisition | +15,272 | -- |
| 2026-09-13 | Lawrence Lin | Chief Financial Officer | Other Acquisition | +30,544 | -- |
| 2026-08-08 | Olga Pirogova | Senior VP & Chief HR Officer | Sale to Issuer | -1,085 | $32.04 |
| 2026-07-30 | Ephraim Starr | Senior Vice President | Private Acquisition | +335 | $24.17 |
| 2026-05-17 | William Cornog | Independent Director | Open Market Acquisition | +10,000 | $16.38 |
| 2026-05-14 | Ephraim Starr | Senior Vice President | Sale to Issuer | -3,621 | $16.02 |
| 2026-04-27 | William Martin | President of Multiomics Business | Other Acquisition | +17,790 | $24.24 |
| 2026-02-05 | Tina Nova | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Martin Madaus | Independent Director | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Robyn Davis | Independent Director | Other Derivative Acquisition | +5,663 | -- |
| 2026-02-04 | Erica McLaughlin | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Dipal Doshi | Independent Director | Other Acquisition | +5,663 | $27.85 |
| 2026-02-04 | Frank Casal | Independent Director | Other Acquisition | +7,243 | $27.85 |
| 2026-02-04 | Quentin Koffey | Independent Director | Other Acquisition | +5,663 | -- |
| 2025-11-23 | Ephraim Starr | Senior Vice President | Other Acquisition | +34,235 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
艾森塔 讨论区 0 条评论